Restructuring

The following summarizes our restructuring plans announced in prior fiscal years. We recognize restructuring expenses as incurred. In addition, we assess the property, plant and equipment associated with the related facilities for impairment. Additional information regarding our restructuring plans is included in our Annual Report on Form 10-K for the year ended March 31, 2011, filed with the SEC on May 27, 2011.

Fiscal 2010 Restructuring Plan

During the fourth quarter of fiscal 2010 we adopted a restructuring plan primarily related to the transfer of the remaining operations in our Erie, Pennsylvania facility to the U.S. headquarters in Mentor, Ohio and the consolidation of our European Healthcare manufacturing operations into two central locations within Europe (the “Fiscal 2010 Restructuring Plan”). In addition, we rationalized certain products and eliminated certain positions.

Since the inception of the Fiscal 2010 Restructuring Plan, we have incurred pre-tax expenses totaling $9,541 related to these actions, of which $8,512 was recorded as restructuring expenses and $1,029 was recorded in cost of revenues. We also expect to incur an additional $1,100 by the end of fiscal 2012. These actions are intended to enhance profitability and improve efficiencies.

Production has ceased in our Switzerland manufacturing facility. We recognized an impairment loss with regard to this facility based on the value of an offer to purchase that was received during the fiscal 2012 third quarter. The following tables summarize our total pre-tax restructuring expenses for the third quarter and first nine months of fiscal 2012 and fiscal 2011:



Three Months Ended December 31, 2011	Fiscal 2010 Restructuring Plan (1)
Severance, payroll, and other related costs	$	7
Asset impairment and accelerated depreciation	1,157
Lease termination obligation and other	3
Total restructuring charges	$	1,167


(1)	Includes $3 in charges recorded in cost of revenues on Consolidated Statements of Income.



Three Months Ended December 31, 2010	Fiscal 2010 Restructuring Plan (1)		Fiscal 2008 Restructuring Plan			Total
Severance, payroll, and other related costs	$	489	$	—		$	489
Asset impairment and accelerated depreciation	—		(289		)	(289		)
Other	7		—			7
Total restructuring charges	$	496	$	(289	)	$	207


(1)	Includes $230 in charges recorded in cost of revenues on Consolidated Statements of Income.



Nine Months Ended December 31, 2011	Fiscal 2010 Restructuring Plan (1)			Fiscal 2008 Restructuring Plan			Total
Severance, payroll, and other related costs	$	(73	)	$	—		$	(73	)
Product rationalization	335			—			335
Asset impairment and accelerated depreciation	1,341			—			1,341
Lease termination obligation and other	3			(152		)	(149		)
Total restructuring charges	$	1,606		$	(152	)	$	1,454


(1)	Includes $(68) in charges recorded in cost of revenues on Consolidated Statements of Income.



Nine Months Ended December 31, 2010	Fiscal 2010 Restructuring Plan (1)		Fiscal 2008 Restructuring Plan			Total
Severance, payroll, and other related costs	$	498	$	—		$	498
Asset impairment and accelerated depreciation	356		(289		)	67
Other	88		—			88
Total restructuring charges	$	942	$	(289	)	$	653

(1)Includes $230 in charges recorded in cost of revenues on Consolidated Statements of Income.

Liabilities related to restructuring activities are recorded as current liabilities on the accompanying Consolidated Balance Sheets within “Accrued payroll and other related liabilities” and “Accrued expenses and other.” The following table summarizes our liabilities related to these restructuring activities:



	Fiscal 2010 Restructuring Plan
			Fiscal 2012
	March 31, 2011		Provision			Payments/ Impairments (1)			December 31, 2011
Severance and termination benefits	$	1,993	$	(73	)	$	(863	)	$	1,057
Product rationalization	—		335			(335		)	—
Asset impairments	—		1,341			(1,341		)	—
Lease termination obligations	1,790		—			152			1,942
Other	193		3			(107		)	89
Total	$	3,976	$	1,606		$	(2,494	)	$	3,088

(1) Certain amounts reported include the impact of foreign currency movements relative to the U.S. dollar.